(Reuters) - Sun Pharmaceutical Industries Ltd, India's largest drugmaker by market capitalisation, posted a surprise quarterly loss on Tuesday, hurt by a one-time charge due to a legal settlement.
Net loss came in at 2.19 billion rupees ($30.15 million) for the quarter ended Sept. 30, compared with a profit of 9.12 billion rupees a year earlier, Sun Pharma said https://www.bseindia.com/xml-data/corpfiling/AttachLive/45c41034-691b-4a84-84b4-a2e0e0f6d530.pdf.
Analysts on average expected a profit of 10.35 billion rupees, according to IBES data from Refinitiv.
Total revenue from operations rose 4.3 percent to 69.38 billion rupees.
($1 = 72.6425 Indian rupees)
(Reporting by Tanvi Mehta and Arnab Paul in Bengaluru; Editing by Subhranshu Sahu)
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)